40 completed. 40 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 40 | Completed 40 |
Follow ziprasidone: new trials by email Literature Review of ziprasidone trials Research Report on ziprasidone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients Olanzapine, Amisulpride, Risperidone - Schizophrenia, Schizophrenia and Disorders With Psychotic Features | Phase 4 | Completed | Technical University of Munich | 21 | 2015-02-01 | 2018-10-11 |
| Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad) ziprasidone - Medication Adherence, Bipolar Disorder | Phase 4 | Completed | University Hospitals Cleveland Medical Center | 30 | 2011-01-01 | 2014-12-30 |
| Effectiveness of Ziprasidone for Patients With Schizophrenia Ziprasidone - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | Soonchunhyang University Hospital | 67 | 2010-09-01 | 2014-11-19 |
| Antipsychotics and Gene Expression in Soft Tissues olanzapine, ziprasidone, placebo - Schizophrenia, Diabetes | Phase 4 | Completed | Medical University of Vienna | 16 | 2010-07-01 | 2017-03-23 |
| Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) Ziprasidone, Placebo - Bipolar Disorder, Panic Disorder | Phase 4 | Completed | VA Palo Alto Health Care System | 49 | 2010-04-01 | 2025-04-08 |
| Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder ziprasidone, Sugar pill - Depression, Bipolar Disorder | Phase 4 | Completed | Tufts Medical Center | 49 | 2010-02-01 | 2017-02-24 |
| Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome Ziprasidone, Aripiprazole - Schizophrenia | Phase 4 | Completed | University of Malaya | 175 | 2009-05-01 | 2012-11-27 |
| An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression ziprasidone hydrochloride, placebo - Depression, Bipolar | Phase 4 | Completed | Queen's University | 14 | 2009-02-01 | 2015-12-16 |
| Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics Aripiprazole or Perphenazine, Metformin, Olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole, asenapine, iloperidone, lurasidone, paliperidone, or olanzapine/fluoxetine - Psychotic Disorders | Phase 4 | Completed | Johns Hopkins University | 127 | 2009-01-01 | 2017-04-25 |
| Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up Aripiprazole, Quetiapine, Ziprasidone - Schizophrenia, Psychotic Disorders | Phase 4 | Completed | Fundación Marques de Valdecilla | 203 | 2008-10-01 | 2017-03-14 |
| Ziprasidone in Pediatric Bipolar Disorder Ziprasidone - Bipolar Disorder | Phase 4 | Completed | Baylor College of Medicine | 28 | 2007-02-01 | 2019-10-22 |
| Geodon in Weight Loss Study for Bipolar Disorders Ziprasidone/Geodon - Bipolar Disorder | Phase 4 | Completed | Stanford University | 25 | 2007-01-01 | 2017-05-09 |
| Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone ziprasidone - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 255 | 2006-11-01 | 2021-03-29 |
| Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes Switch, Control - Schizophrenia, Metabolic Syndrome X | Phase 4 | Completed | Veterans Medical Research Foundation | 77 | 2006-06-01 | 2020-10-30 |
| Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy Risperidone microspheres, Risperidone, Olanzapine - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | Northwell Health | 357 | 2006-05-01 | 2018-07-10 |
| Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis Aripiprazole, Quetiapine, Ziprasidone - Schizophrenia, Psychotic Disorders | Phase 4 | Completed | Fundación Marques de Valdecilla | 203 | 2005-10-01 | 2017-03-14 |
| Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up Aripiprazole, Quetiapine, Ziprasidone - Schizophrenia, Psychotic Disorders | Phase 4 | Completed | Fundación Marques de Valdecilla | 136 | 2005-10-01 | 2017-03-14 |
| Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics ziprasidone - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | Bronx Psychiatric Center | 40 | 2005-05-01 | 2020-05-01 |
| Influence of Treatment With Olanzapine or Ziprasidone on Transcapillary Glucose Transport in Human Skeletal Muscle ziprasidone or olanzapine, hyperinsulinaemic euglycaemic clamp, microdialysis (skeletal muscle) - Healthy Male Volunteers | Phase 4 | Completed | Medical University of Vienna | 2005-04-01 | 2006-10-18 | |
| Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression Ziprasidone - Bipolar II Disorder, Major Depressive Episode | Phase 4 | Completed | The Medical Research Network | 30 | 2005-02-01 | 2013-06-19 |
Showing 20 of 40. Sign in to see all of them.
Schizophrenia (25) · Psychotic Disorders (17) · Bipolar Disorder (9) · Metabolic Syndrome (3) · Depression (2) · Diabetes Mellitus (2) · Insulin Resistance (2) · Mania (2) · Weight Gain (2) · Affective Disorders, Psychotic (1) · Anxiety Disorders (1) · Depressive Disorder, Major (1) · Generalized Anxiety Disorder (1) · Medication Adherence (1) · Mood Disorders (1)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (8) · Fundación Marques de Valdecilla (3) · Medical University of Vienna (2) · Northwell Health (2) · Baylor College of Medicine (1) · Bronx Psychiatric Center (1) · Central Institute of Mental Health, Mannheim (1) · Charite University, Berlin, Germany (1) · Chonbuk National University Hospital (1) · Creighton University (1) · Eli Lilly and Company (1) · Icahn School of Medicine at Mount Sinai (1) · Johns Hopkins University (1) · Massachusetts General Hospital (1) · Medical College of Wisconsin (1)
United States (18) · Spain (5) · Germany (4) · Brazil (3) · Austria (2) · Greece (2) · South Korea (2) · Turkey (Türkiye) (2) · Canada (1) · Egypt (1) · Jordan (1) · Kuwait (1) · Lebanon (1) · Malaysia (1) · Mexico (1)
Benedicto Crespo-Facorro, Professor (3) · Ahmad Hatim Sulaiman, MBBS,MPM (1) · Anusha Baskaran, BScH (1) · Ashwin Patkar, MD (1) · Christoph Correll, MD (1) · David C Henderson, MD (1) · Frederick Petty, MD, PhD (1) · Gloria Reeves, MD (1) · Han Yong Jung, MD, PhD (1) · Jeffrey A Lieberman, MD (1) · Jeffrey Grace, MD (1) · Jonathan M. Meyer, MD (1) · Joseph Biederman, MD (1) · Kirti Saxena, MD (1)
PMID 29856773, PMID 30097769, PMID 16172203, PMID 16585434, PMID 16585435, PMID 17151158, PMID 17151159, PMID 19640511, PMID 20334680, PMID 20816031, PMID 20868641, PMID 20879830, PMID 21041245, PMID 21536693, PMID 21884578, PMID 22000938, PMID 22290266, PMID 22316567, PMID 22480442, PMID 23235268, PMID 23246610, PMID 23727135, PMID 24028745, PMID 24030617, PMID 24079855, PMID 24183751, PMID 24345758, PMID 24400912, PMID 24490070, PMID 24524169, PMID 24569099, PMID 24581550, PMID 24630140, PMID 24717389, PMID 24726579, PMID 24850369, PMID 24862257, PMID 24870446, PMID 25075930, PMID 25562591, PMID 25567425, PMID 25668654, PMID 25679125, PMID 26443050, PMID 26475577, PMID 26479222, PMID 26581028, PMID 26973142, PMID 27180047, PMID 28441618
K23MH074540 (1), N01MH090001 (1), N01MH90001 (1), R01MH059312 (1), R01MH060845 (1), R01MH080270 (1), U01MH070007 (1), U01MH070008 (1), U01MH070009 (1), U01MH070010 (1), U01MH070011 (1), U01MH070012 (1), U01MH070016 (1), U01MH070017 (1), U01MH070023 (1)